Please assess the completion status of the following clinical trial:

Trial Title: Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Moderate to Severe Cancer Pain

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patient is at least 18 and no older than 75 years of age at the time of screening~* Patient has a diagnosis of cancer~* Patient has moderate to severe pain that is related to cancer or its treatment and is expected to last indefinitely and is currently taking an around-the-clock opioid to treat his/her pain~* Patient is already receiving opioid therapy, has demonstrated opioid tolerance~* A responsible adult caregiver is available in the event of an emergency at home~Exclusion Criteria:~* Patient has uncontrolled or rapidly escalating pain as determined by the investigator~* Patient has a history of substance abuse or has a substance abuse disorder

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- ZR-02-01 (Type: EXPERIMENTAL): ZR-02-01 matrix transdermal fentanyl patch

Based on this trial design, predict the completion outcome and termination type (if applicable).